Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sascha Göttert
Observed names:
Göttert, Sascha,
S Göttert,
Sascha Goettert,
Sascha Göttert
Institutions:
University Hospital Regensburg,
Leibniz Institute for Immunotherapy
Observed institutions:
TUM Klinikum,
University Hospital Regensburg,
Christian-Albrechts-Universität zu Kiel,
Leibniz Institute for Immunotherapy,
Technical University of Munich
ORCID:
0000-0001-5177-3909
Observed ORCID:
0000-0001-5177-3909
OpenAlex ID:
A5063553163
RIG-I activation is critical for responsiveness to checkpoint blockade
2019
·
Simon Heidegger
, Alexander Wintges
, et al.
·
Science Immunology
·
141
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors
2023
·
Laura Joachim
, Sascha Göttert
, et al.
·
EBioMedicine
·
73
PDF
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation
2024
·
Erik Thiele Orberg
, Elisabeth Meedt
, et al.
·
Nature Cancer
·
49
PDF
KDEL Receptor 1 Contributes to Cell Surface Association of Protein Disulfide Isomerases
2019
·
Anne-Kathrin Bartels
, Sascha Göttert
, et al.
·
Cellular Physiology and Biochemistry
·
27
The SNP rs4252548 (R112H) which is associated with reduced human height compromises the stability of IL-11
2017
·
Juliane Lokau
, Sascha Göttert
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
25
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration
2025
·
Sascha Göttert
, Erik Thiele Orberg
, et al.
·
Nature Communications
·
24
PDF
Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy
2023
·
Simon Heidegger
, Florian Stritzke
, et al.
·
Cell Reports Medicine
·
24
PDF
Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells
2019
·
Julius C. Fischer
, Michael Bscheider
, et al.
·
Scientific Reports
·
15
PDF
Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury
2025
·
Julius C. Fischer
, Sascha Göttert
, et al.
·
Signal Transduction and Targeted Therapy
·
11
PDF
IFN-Gamma Is Crucial for the Counterbalance of T Cell-Mediated Injury to the Intestinal Stem Cell Compartment By Regulatory T Cells in Mice and Humans
2022
·
Sascha Göttert
, Julius Clemens Fischer
, et al.
·
Blood
·
2
IFN-Gamma Producing Regulatory T Cells Counterbalance T Cell-Mediated Injury to the Intestinal Stem Cell Compartment in Mice and Humans
2021
·
Sascha Göttert
, Julius Clemens Fischer
, et al.
·
Blood
·
2
Microbial-Derived Metabolites Induce Epithelial Recovery Via the Sting Pathway in Mice and Men and Protect from Graft-Versus-Host Disease
2021
·
Erik Thiele Orberg
, Sascha Göttert
, et al.
·
Blood
·
2
Modulation of the RNA‐sensing RIG/MAVS pathway bypasses resistance to hypomethylating agents in acute myeloid leukemia
2026
·
Nadia El Khawanky
, Tatiana Nedelko
, et al.
·
HemaSphere
PDF
Opposing functions of gut immunomodulatory metabolites on CAR-T therapy
2026
·
Markus Perl
, Severin Guetter
, et al.
·
Cell
PDF
Timed STING Inhibition Mitigates Gastrointestinal GvHD While Preserving Graft-versus-Leukemia Activity After Allo-HSCT
2026
·
Chiara Suriano
, Omer Khalid
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Targeted LC-MS/MS Metabolomics Data: ICA/IVA/VA Distribution in Mouse Heart Blood, Portal Vein Blood, and Stool
2026
·
Perl, Markus
, Guetter, Severin
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Targeting ZC3H12C improves T cell persistence and antitumor function in adoptive T cell therapy
2026
·
Gayatri Kavishwar
, Markus Perl
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Immunomodulatory metabolites define long-term gut microbiome recovery after allogeneic HCT and associate with improved survival and reduced relapse related mortality
2026
·
Alix Schwarz
, Tina Eismann
, et al.
·
medRxiv
PDF
Multi-faceted influence of immunomodulatory metabolites on CAR-T cell therapy
2025
·
Dhyani Shah
, Markus Perl
, et al.
·
Blood
PDF
Timed inhibition of the sting pathway improves tissue regeneration and prevents GVHD following allo-HSCT
2025
·
Sascha Göttert
, Chiara Suriano
, et al.
·
Blood
Immunomodulatory Microbial Metabolites Protect Against Graft-Vs-Host Disease and Enhance Anti-Leukemia Responses in Mice and Patients Receiving Stem Cell Transplantation
2024
·
Sascha Göttert
, Erik Thiele-Orberg
, et al.
·
Blood
PDF
Bacteriophage-modulated Production of Intestinal Immuno-modulatory Metabolites is Associated with Protection in Allogeneic Stem Cell Transplantation Patients
2023
·
Orberg, Erik Thiele
, Meedt, Elisabeth
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Immunomodulatory Microbial Metabolites Identified in Allo-SCT Patients Protect from GvHD By Sting Dependent Modulation of Intestinal Tissue Homeostasis
2022
·
Sascha Göttert
, Erik Thiele-Orberg
, et al.
·
Blood
P04.09 Development of a dendritic cell vaccine against hepatocellular carcinoma using VSV-NDV
2020
·
J Gold
, L Hanesch
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Type I Interferon Signaling before Hematopoietic Stem Cell Transplantation Lowers Donor T Cell Activation Via Reduced Allogenicity of Recipient Cells
2019
·
Erik Thiele Orberg
, Julius Clemens Fischer
, et al.
·
Blood
Show more works
View as search
Works count:
26
Citation count:
395
H-index:
9
I10-index:
9
Year
Topic
Type